PTPN2 inhibitor ABBV-CLS-484
Term · Oncology and biomedicine · MLC-T-ONC-016290
An orally bioavailable inhibitor of the T-cell specific tyrosine-protein phosphatase non-receptor type 2 (PTPN2), with potential immunomodulating and antineoplastic activities. Upon oral administration, PTPN2 inhibitor ABBV-CLS-484 specifically targets and binds to PTPN2. This prevents PTPN2-mediated signal transduction pathways and may activate anti-tumor T-cell immune responses. It may also sensitize tumor cells to immunotherapeutics. PTPN2 negatively regulates TCR and cytokine signaling needed for T-cell function, homeostasis and differentiation.
| Identifier | MLC-T-ONC-016290 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016290",
"term": "PTPN2 inhibitor ABBV-CLS-484",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable inhibitor of the T-cell specific tyrosine-protein phosphatase non-receptor type 2 (PTPN2), with potential immunomodulating and antineoplastic activities. Upon oral administration, PTPN2 inhibitor ABBV-CLS-484 specifically targets and binds to PTPN2. This prevents PTPN2-mediated signal transduction pathways and may activate anti-tumor T-cell immune responses. It may also sensitize tumor cells to immunotherapeutics. PTPN2 negatively regulates TCR and cytokine signaling needed for T-cell function, homeostasis and differentiation.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ptpn2-inhibitor-abbv-cls-484/"
}
Record 13,856 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.